Reaction Details Report a problem with these data
Target
Protein S100-A9
Ligand
BDBM299054
Substrate
n/a
Meas. Tech.
S100A9-RAGE inhibition assay
IC50
>1000±n/a nM
Citation
 Fritzson, I; Liberg, D; East, S; Mackinnon, C; Prevost, N N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors US Patent  US10125125 Publication Date 11/13/2018 
Target
Name:
Protein S100-A9
Synonyms:
CAGB | CFAG | Calgranulin-B | Calprotectin L1H subunit | Leukocyte L1 complex heavy chain | MRP-14 | MRP14 | Migration inhibitory factor-related protein 14 | S100 calcium-binding protein A9 | S100A9 | S10A9_HUMAN | p14
Type:
Enzyme Catalytic Domain
Mol. Mass.:
13239.84
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
114
Sequence:
MTCKMSQLERNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMARLTWASHEKMHEGDEGPGHHHKPGLGEGTP
  
Inhibitor
Name:
BDBM299054
Synonyms:
5-bromo-6-chloro-N-[3-hydroxy-5-(propan-2-yl)pyridin-2-yl]pyridine-3-sulfonamide | US10125125, Example 11
Type:
Small organic molecule
Emp. Form.:
C13H13BrClN3O3S
Mol. Mass.:
406.683
SMILES:
CC(C)c1cnc(NS(=O)(=O)c2cnc(Cl)c(Br)c2)c(O)c1
Structure:
Search PDB for entries with ligand similarity: